News

Rare mutations could be a key to finding new treatments for lupus.

Treatments for Ewing sarcoma have been essentially the same 30 years. Dr. Casey Langdon wants to change that.

Could the way we preserve donor milk shape preemie gut health? A new MUSC study connects the dots between storage practices and GI outcomes.

Those born with both Down syndrome and congenital heart defects can still score just as high in quality of life and community engagement.

MUSC helps lead study finding nerve blocks reduce pain in kids with broken legs.

Children who do not meet inclusion criteria for current peds studies now have a chance through an innovative program.

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

The CREW program encourages early-career women in science to become entrepreneurs.

MUSC’s ReJoyce Green, Ph.D., leads study highlighted in prestigious publication showing which factors may predict substance use in adolescents.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.